BrainCells will screen targets and compounds for Lundbeck to develop.

BrainCells formed a research collaboration with H. Lundbeck. The company will use its neurogenesis-based technology to screen central nervous system (CNS) targets and compounds.

In performing the screening, BrainCells will determine whether or not the targets or compounds promote neurogenesis. Lundbeck will advance the appropriate targets or compounds through development.

Previous articleBeckman Coulter’s Shares Slip with $1.55B Acquisition of Biosite
Next articleEli Lilly Launches $150M Expansion in Singapore